|
Subject: The treatment ratio pharm. Bioequivalence
The bioequivalence criterion was that the 90% confidence interval of the ratio of incremental recovery, t½, AUC and CL (primary endpoint) and AUClast and Cmax (secondary endpoints) between treatments must be contained within the bioequivalence interval, 0.8-1.25, in order to claim bioequivalence between the two treatments. The criterion was in accordance with the EU Note for Guidance on the Investigation of Bioavailability and Bioequivalence
The treatment ratio was estimated from the model based on data adjusted for actual dose and product strength and excluding outliers and these values are presented together with a 90% confidence interval in ХХ and YY were found to be bioequivalent, based on primary and secondary pharmacokinetic parameters.Подскажите, пожалуйста, как здесь назвать "treatment ratio"?
|